LUMAKRAS is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC). LUMAKRAS (sotorasib) tablets can be imported for personal use under "patient name basis" treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.
Therapeutic indications and Usage
LUMAKRAS is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC): • that has spread to other parts of the body or cannot be removed by surgery, and whose tumor has an abnormal KRAS G12C gene, and who have received at least one prior treatment for their cancer. Your healthcare provider will perform a test to make sure that LUMAKRAS™ is right for you. It is not known if LUMAKRAS is safe and effective in children.
DISEASE INDICATIONS: Lung Cancer
MANUFACTURER: Amgen Inc.
DOSAGE FORMS AND STRENGTHS: Tablets: 120 mg
MEDICINE APPROVED BY: European Medical Agency (EMA), Food and Drug Administration (FDA), Medicines & Healthcare products Regulatory Agency (MHRA)
Source Details: Patient Information
Patient Name Basis Treatment IPN, New Delhi can facilitate patient to import of "LUMAKRAS (sotorasib) tablets" in quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP).
Health Professional In India
If you have any question, please email IPN Support Team or Call Indian Pharma Network for LUMAKRAS (sotorasib) tablets price list or cost in India. on
Mr. Tarun:- +91 9891 296 838
Mr. Neeraj:- +91 9811 747 774
We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.
LUMAKRAS is an inhibitor of the RAS GTPase family indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test, who have received at least one prior systemic therapy. (1) This indication is approved under accelerated approval based on overall response rate (ORR) and duration of response (DOR). Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).
Source content : www.accessdata.fda.gov
IPN, New Delhi can facilitate patient to import of "LUMAKRAS (sotorasib) tablets" in quantities for personal use. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Visakhapatnam, Surat, Jaipur, Coimbatore, Kanpur, Nagpur, Raipur, Kochi, Kozhikode, Nashik, Salem, Thiruvananthapuram, Madurai, Jodhpur, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India. with over 20 years of domain experience.
For procurement cost of LUMAKRAS (sotorasib) tablets in India, Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the LUMAKRAS (sotorasib) tablets medicine cost price in India.
The order for LUMAKRAS (sotorasib) tablets will be confirmed only after
1. submitting Form 12A, along with the prescription of the Registered Medical Practitioner (RMP).
2. Permission from obtained from the office of the Drugs Controller General (India).
3. Availability of LUMAKRAS (sotorasib) tablets from authorised distributor.
LUMAKRAS is a prescription medicine used to treat adults with non-small cell lung cancer (NSCLC): • that has spread to other parts of the body or cannot be removed by surgery, and • whose tumor has an abnormal KRAS G12C gene, and • who have received at least one prior treatment for their cancer. Your healthcare provider will perform a test to make sure that LUMAKRAS is right for you. It is not known if LUMAKRAS is safe and effective in children. Active Ingredient: sotorasib Inactive Ingredients: microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, and magnesium stearate. Tablet film coating material contains polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc, and iron oxide yellow. LUMAKRAS is supplied as film-coated tablets for oral use containing 120 mg of sotorasib. Inactive ingredients in the tablet core are microcrystalline cellulose, lactose monohydrate, croscarmellose sodium, and magnesium stearate. The film coating material consists of polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc, and iron oxide yellow. LUMAKRAS (sotorasib) 120 mg tablets are yellow, oblong-shaped, film-coated, debossed with “AMG” on one side and “120” on the opposite side are supplied as follows: • Carton containing two bottles of 120 tablets with child-resistant closure, NDC 55513-488-02 • Carton containing one bottle of 240 tablets with child-resistant closure, NDC 55513-488-24
LUMAKRAS (sotorasib) tablets, for oral use. Initial U.S. Approval: 2021.
DOSAGE FORMS AND STRENGTHS: Tablets: 120 mg
For LUMAKRAS (sotorasib) tabletsIndications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details
Full prescribing information [FDA]: Lumakras (sotorasib) [PDF] Amgen, May 2021
KRAS G12C inhibition Amgen, cited May 2021
Sotorasib (AMG 510) Precision Cancer Medicine Targets KRAS NSCLC Cancer Connect, Feb 2021
Amgen's high-profile cancer med Lumakras set for rollout in England thanks to NHS access deal Fiercepharma.com, Sep 2021
Step 1. Send a request for your medicine online:-
Applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP).Step 2. Verification of documents:-
We verify your a prescription and necessary documents to import drugs in quantities for personal use.Step 3. Permission to Import:-
After getting approval of Drugs Controller General (India), we start the process to import of drugs as mentioned in prescription for personal use.Step 4. We source your medicine:-
Our expert sourcing team work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.Step 5. Delivery of medicine:-
After you have accepted our offer, our experienced logistics team will arrange all the shipping and transportation of your medicine. Doctor’s Prescription –
We would require prescription from Registered Medical Practitioner (RMP) stating product name, dosage, duration of treatment and diagnosis.
Patient’s Medical history –
We would require all test reports and medical reports of the patient for last 3 months.
Patient’s Identity card –
We will require scan copy of patient’s identity card and proof of residence to initiate documentation process.
Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. Indian Pharma Network, New Delhi can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.
Send your query to find out -
LUMAKRAS (sotorasib) tablets price in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
LUMAKRAS (sotorasib) tablets price in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
LUMAKRAS (sotorasib) tablets price in North America – Mexico.
LUMAKRAS (sotorasib) tablets price in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
LUMAKRAS (sotorasib) tablets price in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
LUMAKRAS (sotorasib) tablets price in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
LUMAKRAS (sotorasib) tablets price in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
LUMAKRAS (sotorasib) tablets price in Australia and New Zealand.
Your order will be shipped to you by our partner couriers, such as DHL, UPS and specialised cold chain couriers. If you would like your order to be shipped by a specific courier, please inform us when you place the order. Our standard delivery time varies from 5 to 10 working days. The shipping cost depends on the medicine and the destination country. After making an enquiry, you will receive a detailed quote that includes the shipping costs.
